Growth hormone (GH) treatment does not restore endothelial function in children with GH deficiency
BACKGROUND: In adults with growth hormone (GH) deficiency (GHD), GH treatment restores impaired endothelial function, a precursor of cardiovascular disease. Its effect in children with GHD is unknown.
METHODS: Three months of GH (0.3 mg/kg/wk) were given to nine children with GHD. Endothelial function was measured via reactive hyperemic response. Forearm blood flow (FBF, strain gauge plethysmography) was measured before and after 5 min of upper arm arterial occlusion. Blood pressure and lipid, insulin and glucose levels were measured. Pretreatment endothelial function was compared to 18 previously studied control children.
RESULTS: Percent fall in forearm vascular resistance was greater in controls (81.2 +/- 1.9%) than in children with GHD (69.6 +/- 5.3%, p = 0.021) but was not affected by GH (60.6 +/- 7.5%). GH markedly increased HOMAIR (21 +/- 7 versus 43 +/- 8, p = 0.004). Plasma lipid levels did not significantly differ.
CONCLUSION: These results indicate that endothelial function is impaired in children with GHD. GH therapy does not restore the impairment.
Errataetall: |
CommentIn: J Pediatr Endocrinol Metab. 2008 Apr;21(4):319-21. - PMID 18556962 |
---|---|
Medienart: |
Artikel |
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Journal of pediatric endocrinology & metabolism : JPEM - 21(2008), 4 vom: 03. Apr., Seite 323-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hoffman, Robert P [VerfasserIn] |
---|
Themen: |
12629-01-5 |
---|
Anmerkungen: |
Date Completed 18.08.2008 Date Revised 07.09.2019 published: Print CommentIn: J Pediatr Endocrinol Metab. 2008 Apr;21(4):319-21. - PMID 18556962 Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM180242989 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM180242989 | ||
003 | DE-627 | ||
005 | 20231223155138.0 | ||
007 | tu | ||
008 | 231223s2008 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0601.xml |
035 | |a (DE-627)NLM180242989 | ||
035 | |a (NLM)18556963 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hoffman, Robert P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Growth hormone (GH) treatment does not restore endothelial function in children with GH deficiency |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 18.08.2008 | ||
500 | |a Date Revised 07.09.2019 | ||
500 | |a published: Print | ||
500 | |a CommentIn: J Pediatr Endocrinol Metab. 2008 Apr;21(4):319-21. - PMID 18556962 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: In adults with growth hormone (GH) deficiency (GHD), GH treatment restores impaired endothelial function, a precursor of cardiovascular disease. Its effect in children with GHD is unknown | ||
520 | |a METHODS: Three months of GH (0.3 mg/kg/wk) were given to nine children with GHD. Endothelial function was measured via reactive hyperemic response. Forearm blood flow (FBF, strain gauge plethysmography) was measured before and after 5 min of upper arm arterial occlusion. Blood pressure and lipid, insulin and glucose levels were measured. Pretreatment endothelial function was compared to 18 previously studied control children | ||
520 | |a RESULTS: Percent fall in forearm vascular resistance was greater in controls (81.2 +/- 1.9%) than in children with GHD (69.6 +/- 5.3%, p = 0.021) but was not affected by GH (60.6 +/- 7.5%). GH markedly increased HOMAIR (21 +/- 7 versus 43 +/- 8, p = 0.004). Plasma lipid levels did not significantly differ | ||
520 | |a CONCLUSION: These results indicate that endothelial function is impaired in children with GHD. GH therapy does not restore the impairment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Human Growth Hormone |2 NLM | |
650 | 7 | |a 12629-01-5 |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Journal of pediatric endocrinology & metabolism : JPEM |d 1995 |g 21(2008), 4 vom: 03. Apr., Seite 323-8 |w (DE-627)NLM07560924X |x 2191-0251 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2008 |g number:4 |g day:03 |g month:04 |g pages:323-8 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2008 |e 4 |b 03 |c 04 |h 323-8 |